ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
103.90
+4.29 (4.31%)
At close: Nov 6, 2025, 4:00 PM EST
102.00
-1.90 (-1.83%)
Pre-market: Nov 7, 2025, 6:28 AM EST
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $7.64 billion as of November 7, 2025. Its market cap has increased by 1,058.96% in one year.
Market Cap
7.64B
Enterprise Value
7.68B
1-Year Change
1,058.96%
Ranking
Category
Stock Price
$103.90
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $7.64B, an increase of 3,287.39%. That is a compound annual growth rate of 40.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 7.38B | 1,565.38% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | 582.13M | 95.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |